Literature DB >> 10377145

Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates.

R Blackstock1, K L Buchanan, A M Adesina, J W Murphy.   

Abstract

Early inflammatory responses, delayed-type hypersensitivity (DTH) responses, and cytokine profiles were studied in mice infected by the pulmonary route with either a highly virulent isolate (NU-2) or a weakly virulent isolate (184A) of Cryptococcus neoformans. After infection, NU-2 remained in the lungs and the capsule became more pronounced during the first 24 h, whereas 184A induced an immediate inflammatory reaction and was rapidly cleared from the lungs. Cryptococcal antigen (GXM) appeared in sera early after infection with NU-2 and increased over the entire observation period. There was no detectable GXM in sera from 184A-infected mice. Both C. neoformans isolates induced anticryptococcal cell-mediated immune responses, but the responses had different profiles. DTH in NU-2-infected mice appeared at day 15 after infection and waned by day 21, whereas DTH in 184A-infected mice was present by day 5 and continued to increase. T helper 1 (Th1) cytokines (interleukin 2 [IL-2] and gamma interferon) were made by spleen cells early after infection with either isolate. NU-2-infected mice lost their ability to produce these cytokines, but 184A-infected mice retained it. IL-4, a Th2 cytokine, was not detected in infected mice. The regulatory cytokine IL-10 was made by spleen cells early but not later after infection with the highly virulent isolate and was not produced by spleen cells from 184A-infected mice. IL-10-deficient mice survived an NU-2 infection significantly longer than wild-type mice, suggesting that IL-10 is important in down-regulating the protective immune response. The induction of anergy appears to be responsible for the inability of NU-2-infected mice to control a C. neoformans infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377145      PMCID: PMC116550     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.

Authors:  R Blackstock; J W Murphy
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

Authors:  L Ding; P S Linsley; L Y Huang; R N Germain; E M Shevach
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

3.  Cryptococcus neoformans. 3. Inhibition of phagocytosis.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

4.  Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response.

Authors:  J W Murphy
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 5.  Biological properties of interleukin 10.

Authors:  M Howard; A O'Garra
Journal:  Immunol Today       Date:  1992-06

6.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

Authors:  M Clerici; T A Wynn; J A Berzofsky; S P Blatt; C W Hendrix; A Sher; R L Coffman; G M Shearer
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

7.  Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice.

Authors:  L E Bermudez; J Champsi
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

8.  Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.

Authors:  K L Buchanan; J W Murphy
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

9.  The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection.

Authors:  G B Huffnagle; M F Lipscomb; J A Lovchik; K A Hoag; N E Street
Journal:  J Leukoc Biol       Date:  1994-01       Impact factor: 4.962

10.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.

Authors:  A D'Andrea; M Aste-Amezaga; N M Valiante; X Ma; M Kubin; G Trinchieri
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  36 in total

1.  Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.

Authors:  Rebecca Blackstock
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

2.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

Review 3.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99.

Authors:  Yanmei Zhang; Fuyuan Wang; Kristin C Tompkins; Andrew McNamara; Aditya V Jain; Bethany B Moore; Galen B Toews; Gary B Huffnagle; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

5.  Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection.

Authors:  Seagal Teitz-Tennenbaum; Steven P Viglianti; Jonathan A Roussey; Stuart M Levitz; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2018-08-10       Impact factor: 5.422

6.  Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo.

Authors:  Lauren E Yauch; Michael K Mansour; Shmuel Shoham; James B Rottman; Stuart M Levitz
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells.

Authors:  Rebecca Blackstock; Juneann W Murphy
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung.

Authors:  John J Osterholzer; Rishi Surana; Jami E Milam; Gerald T Montano; Gwo-Hsiao Chen; Joanne Sonstein; Jeffrey L Curtis; Gary B Huffnagle; Galen B Toews; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

9.  Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion.

Authors:  Michal A Olszewski; Mairi C Noverr; Gwo-Hsiao Chen; Galen B Toews; Gary M Cox; John R Perfect; Gary B Huffnagle
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

10.  Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Sailatha Ravi; Sandra Macias; Mattie L Young; Michal A Olszewski; Chad Steele; Floyd L Wormley
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.